MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with E

Erythromycin

Erythromycin 250mg gastro-resistant tablets

Use with caution

Stability notes for Erythromycin 250mg gastro-resistant tablets

Protect from light and moisture. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Erythromycin 250mg gastro-resistant tablets (Sovereign Medical Ltd).

Suppliers (14) of Erythromycin 250mg gastro-resistant tablets
Erythromycin 250mg gastro-resistant tablets (A A H Pharmaceuticals Ltd)
Erythromycin 250mg gastro-resistant tablets (Alliance Healthcare (Distribution) Ltd)
Erythromycin 250mg gastro-resistant tablets (Almus Pharmaceuticals Ltd)
Erythromycin 250mg gastro-resistant tablets (Bristol Laboratories Ltd)
Erythromycin 250mg gastro-resistant tablets (Brown & Burk UK Ltd)
Erythromycin 250mg gastro-resistant tablets (Genesis Pharmaceuticals Ltd)
Erythromycin 250mg gastro-resistant tablets (Medihealth (Northern) Ltd)
Erythromycin 250mg gastro-resistant tablets (Medreich Plc)
Erythromycin 250mg gastro-resistant tablets (Milpharm Ltd)
Erythromycin 250mg gastro-resistant tablets (Noumed Life Sciences Ltd)
Erythromycin 250mg gastro-resistant tablets (Phoenix Healthcare Distribution Ltd)
Erythromycin 250mg gastro-resistant tablets (Sigma Pharmaceuticals Plc)
Erythromycin 250mg gastro-resistant tablets (Sovereign Medical Ltd)
Erythromycin 250mg gastro-resistant tablets (Strides Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.